Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00129337
What this trial is testing

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Tumors
Peregrine Pharmaceuticals 28
Not applicableUnknownNCT03787953
What this trial is testing

A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Chinese PLA General Hospital 400
Early research (Phase 1)Looking for participantsNCT05649345
What this trial is testing

TR64 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Tarapeutics Science Inc. 19
Early research (Phase 1)UnknownNCT05830045
What this trial is testing

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01283945
What this trial is testing

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Institut de Recherches Internationales Servier 134
Early research (Phase 1)Study completedNCT00077077
What this trial is testing

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Daiichi Sankyo
Early research (Phase 1)UnknownNCT05150457
What this trial is testing

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

Who this might be right for
Refractory Solid Tumors
Binacea Pharma, Inc. 48
Very early researchEnded earlyNCT05438667
What this trial is testing

TCR-T Cell Therapy on Advanced Solid Tumors

Who this might be right for
Pancreatic Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Early research (Phase 1)UnknownNCT05060263
What this trial is testing

Of HOT1030 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Huabo Biopharm Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT04770207
What this trial is testing

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Who this might be right for
Hepatocellular CarcinomaSolid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02637687
What this trial is testing

Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 154
Early research (Phase 1)Study completedNCT00275093
What this trial is testing

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

Who this might be right for
Hepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 130
Testing effectiveness (Phase 2)Looking for participantsNCT05405595
What this trial is testing

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 186
Early research (Phase 1)Looking for participantsNCT06299839
What this trial is testing

PAS-004 in Patients With Advanced Solid Tumors

Who this might be right for
RAS MutationNF1 MutationRAF Mutation+1 more
Pasithea Therapeutics Corp. 48
Testing effectiveness (Phase 2)UnknownNCT06082557
What this trial is testing

Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

Who this might be right for
Malignant Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 62
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Testing effectiveness (Phase 2)Study completedNCT02272998
What this trial is testing

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Who this might be right for
Malignant Neoplasm
Sameek Roychowdhury 22
Early research (Phase 1)Study completedNCT04006301
What this trial is testing

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Who this might be right for
NeoplasmsAdvanced Solid TumorsNon-small Cell Lung Cancer+1 more
Janssen Research & Development, LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Next Page